Skip to main content
S

Sai Parenteral's Limited — Investor Relations & Filings

Ticker · SAIPARENT ISIN · INE0H9F01037 LEI · 984500ABF36AF1C83D64 BSE.NS Manufacturing
Filings indexed 5 across all filing types
Latest filing 2026-04-20 Regulatory Filings
Country IN India
Listing BSE.NS SAIPARENT

About Sai Parenteral's Limited

https://www.saiparenterals.com/

Sai Parenteral's Limited specializes in the development, manufacture, and distribution of sterile injectable formulations. The company's core operations focus on a diverse portfolio of parenteral products, including Small Volume Parenterals (SVP), Large Volume Parenterals (LVP), and cephalosporin dry powder injections. Its technical capabilities extend to liquid vials, ampoules, and lyophilized products across multiple therapeutic categories such as anti-infectives, analgesics, and critical care. Utilizing advanced manufacturing infrastructure that complies with Good Manufacturing Practices (GMP), the company provides integrated contract development and manufacturing services (CDMO) alongside its proprietary product range. The organization emphasizes high-quality aseptic processing and formulation stability to meet the requirements of global healthcare providers and institutional markets.

Recent filings

Filing Released Lang Actions
Structural Digital Database
Regulatory Filings
2026-04-20 English
Outcome of Board Meeting
Regulatory Filings
2026-04-20 English
Board Meeting — Other business matters
Regulatory Filings
2026-04-14 English
Updates
Regulatory Filings
2026-04-06 English
Trading Window
Regulatory Filings
2026-04-06 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.